Presented by Doris Wangari, Program for Biosafety Systems (PBS), Kenya, at the Workshop on Animal Genetic Research for Africa (Biosciences for Farming in Africa), Nairobi, 10-11 September 2015
brief presentation about the environmental and health issues associated with transgenic crops
or
impact of transgenic crops or GMO crops on environment and health
Applications of genomics and proteomics pptIbad khan
Applications of genomics and proteomics ppt
genomics and proteomics ppt
in the field of health genomics and proteomics ppt
oncology ppt
biomedical application of genomics and proteomics ppt
agriculture application of genomics and proteomics ppt
proteomics in agriculture ppt
diagnosis of infectious disease ppt
personalized medicine ppt
What is a GMO? Genetically modified organisms (GMOs) are living organisms whose genetic material has been artificially manipulated in a laboratory through genetic engineering. This creates combinations of plant, animal, bacteria, and virus genes that do not occur in nature or through traditional crossbreeding methods.
One specific concern is the possibility for GMOs to negatively affect human health. This could result from differences in nutritional content, allergic response, or undesired side effects such as toxicity, organ damage, or gene transfer.
Contrary to what some believe, GMO crops can actually allow farmers to use less (and less toxic) pesticides on their fields. ... “On average, GM technology adoption has reduced chemical pesticide use by 37%, increased crop yields by 22%, and increased farmer profits by 68%.”
brief presentation about the environmental and health issues associated with transgenic crops
or
impact of transgenic crops or GMO crops on environment and health
Applications of genomics and proteomics pptIbad khan
Applications of genomics and proteomics ppt
genomics and proteomics ppt
in the field of health genomics and proteomics ppt
oncology ppt
biomedical application of genomics and proteomics ppt
agriculture application of genomics and proteomics ppt
proteomics in agriculture ppt
diagnosis of infectious disease ppt
personalized medicine ppt
What is a GMO? Genetically modified organisms (GMOs) are living organisms whose genetic material has been artificially manipulated in a laboratory through genetic engineering. This creates combinations of plant, animal, bacteria, and virus genes that do not occur in nature or through traditional crossbreeding methods.
One specific concern is the possibility for GMOs to negatively affect human health. This could result from differences in nutritional content, allergic response, or undesired side effects such as toxicity, organ damage, or gene transfer.
Contrary to what some believe, GMO crops can actually allow farmers to use less (and less toxic) pesticides on their fields. ... “On average, GM technology adoption has reduced chemical pesticide use by 37%, increased crop yields by 22%, and increased farmer profits by 68%.”
Safety and toxicity evaluation of probiotics foodsSukhveerSingh31
Probiotics can also be defined as “Live microorganisms that when administered in adequate amounts confer a health benefit on the host” (Council for Agricultural Science and Technology).
For more information, you can visit https://www.creative-proteomics.com/services/protein-post-translational-modification-analysis.htm. In this video, we introduce some commonly used methods to detect PPIs and techniques for proteome-scale interactome maps.
Use of reporter genes in the process of selection of the transformants from the non transformants, and the current use of these reporter genes as the Desired genes.
Transgenic animal production and its applicationkishoreGupta17
A genetically modified animal with the heterologous gene of interest being inserted for the purpose of biopharming or make a diseased model to study the consequences of disease and its probable therapy
Safety and toxicity evaluation of probiotics foodsSukhveerSingh31
Probiotics can also be defined as “Live microorganisms that when administered in adequate amounts confer a health benefit on the host” (Council for Agricultural Science and Technology).
For more information, you can visit https://www.creative-proteomics.com/services/protein-post-translational-modification-analysis.htm. In this video, we introduce some commonly used methods to detect PPIs and techniques for proteome-scale interactome maps.
Use of reporter genes in the process of selection of the transformants from the non transformants, and the current use of these reporter genes as the Desired genes.
Transgenic animal production and its applicationkishoreGupta17
A genetically modified animal with the heterologous gene of interest being inserted for the purpose of biopharming or make a diseased model to study the consequences of disease and its probable therapy
Developing national policy and technical regulation for aflatoxin control in ...Francois Stepman
12 December 2018. Ghana inaugurated the National Steering Committee for Aflatoxin Control. Rose Omari (PhD.)
Science and Technology Policy Research Institute
Council for Scientific and Industrial Research
Accra, Ghana
Jose Falck Zepeda presentation on biotechnology and developing countries Geor...Jose Falck Zepeda
In my presentation I describe the foundation frameworks for improving crop production in developing countries firmly based on the successes, failures and issues identified during the Green Revolution. I describe the status of Genetically Modified Biotechnology in developed and developing countries,describe the regulatory activities that examine environmental/biodiversity and food/feed safety, as GM bio-technologies are the only regulated biotechnologies globally with a few exceptions. I describe our experiences and issues related to socioeconomic assessments of potential and actual impacts of GM crops in Uganda, Philippines, Colombia and Honduras. I summarize some lessons and conclusions learned in this process.
Current status of the development, regulation and use of bio-pesticides in Ug...ILRI
Presented by Samuel Kyamanywa, Makerere University, at the Regional Experts Workshop on Development, Regulation and Use of Bio-pesticides in East Africa, Nairobi, Kenya, 22–23 May 2014
Antimicrobial Resistance: A One Health Challenge for Joint ActionSIANI
Presented by Juan Lubroth at the seminar "Antimicrobial resistance; linkages between humans, livestock and water in peri-urban areas" at the World Water Week, 29th August 2016.
Small ruminant keepers’ knowledge, attitudes and practices towards peste des ...ILRI
Presentation by Guy Ilboudo, Abel Sènabgè Biguezoton, Cheick Abou Kounta Sidibé, Modou Moustapha Lo, Zoë Campbell and Michel Dione at the 6th Peste des Petits Ruminants Global Research and Expertise Networks (PPR-GREN) annual meeting, Bengaluru, India, 28–30 November 2023.
Small ruminant keepers’ knowledge, attitudes and practices towards peste des ...ILRI
Poster by Guy Ilboudo, Abel Sènabgè Biguezoton, Cheick Abou Kounta Sidibé, Modou Moustapha Lo, Zoë Campbell and Michel Dione presented at the 6th Peste des Petits Ruminants Global Research and Expertise Networks (PPR-GREN) annual meeting, Bengaluru, India, 29 November 2023.
A training, certification and marketing scheme for informal dairy vendors in ...ILRI
Presentation by Silvia Alonso, Jef L. Leroy, Emmanuel Muunda, Moira Donahue Angel, Emily Kilonzi, Giordano Palloni, Gideon Kiarie, Paula Dominguez-Salas and Delia Grace at the Micronutrient Forum 6th Global Conference, The Hague, Netherlands, 16 October 2023.
Milk safety and child nutrition impacts of the MoreMilk training, certificati...ILRI
Poster by Silvia Alonso, Emmanuel Muunda, Moira Donahue Angel, Emily Kilonzi, Giordano Palloni, Gideon Kiarie, Paula Dominguez-Salas, Delia Grace and Jef L. Leroy presented at the Micronutrient Forum 6th Global Conference, The Hague, Netherlands, 16 October 2023.
Food safety research in low- and middle-income countriesILRI
Presentation by Hung Nguyen-Viet at the first technical meeting to launch the Food Safety Working Group under the One Health Partnership framework, Hanoi, Vietnam, 28 September 2023
Presentation by Hung Nguyen-Viet at the first technical meeting to launch the Food Safety Working Group under the One Health Partnership framework, Hanoi, Vietnam, 28 September 2023
Reservoirs of pathogenic Leptospira species in UgandaILRI
Presentation by Lordrick Alinaitwe, Martin Wainaina, Salome Dürr, Clovice Kankya, Velma Kivali, James Bugeza, Martin Richter, Kristina Roesel, Annie Cook and Anne Mayer-Scholl at the University of Bern Graduate School for Cellular and Biomedical Sciences Symposium, Bern, Switzerland, 29 June 2023.
Assessing meat microbiological safety and associated handling practices in bu...ILRI
Presentation by Patricia Koech, Winnie Ogutu, Linnet Ochieng, Delia Grace, George Gitao, Lily Bebora, Max Korir, Florence Mutua and Arshnee Moodley at the 8th All Africa Conference on Animal Agriculture, Gaborone, Botswana, 26–29 September 2023.
Ecological factors associated with abundance and distribution of mosquito vec...ILRI
Poster by Max Korir, Joel Lutomiah and Bernard Bett presented the 8th All Africa Conference on Animal Agriculture, Gaborone, Botswana, 26–29 September 2023.
Practices and drivers of antibiotic use in Kenyan smallholder dairy farmsILRI
Poster by Lydiah Kisoo, Dishon M. Muloi, Walter Oguta, Daisy Ronoh, Lynn Kirwa, James Akoko, Eric Fèvre, Arshnee Moodley and Lillian Wambua presented at Tropentag 2023, Berlin, Germany, 20–22 September 2023.
The ability to recreate computational results with minimal effort and actionable metrics provides a solid foundation for scientific research and software development. When people can replicate an analysis at the touch of a button using open-source software, open data, and methods to assess and compare proposals, it significantly eases verification of results, engagement with a diverse range of contributors, and progress. However, we have yet to fully achieve this; there are still many sociotechnical frictions.
Inspired by David Donoho's vision, this talk aims to revisit the three crucial pillars of frictionless reproducibility (data sharing, code sharing, and competitive challenges) with the perspective of deep software variability.
Our observation is that multiple layers — hardware, operating systems, third-party libraries, software versions, input data, compile-time options, and parameters — are subject to variability that exacerbates frictions but is also essential for achieving robust, generalizable results and fostering innovation. I will first review the literature, providing evidence of how the complex variability interactions across these layers affect qualitative and quantitative software properties, thereby complicating the reproduction and replication of scientific studies in various fields.
I will then present some software engineering and AI techniques that can support the strategic exploration of variability spaces. These include the use of abstractions and models (e.g., feature models), sampling strategies (e.g., uniform, random), cost-effective measurements (e.g., incremental build of software configurations), and dimensionality reduction methods (e.g., transfer learning, feature selection, software debloating).
I will finally argue that deep variability is both the problem and solution of frictionless reproducibility, calling the software science community to develop new methods and tools to manage variability and foster reproducibility in software systems.
Exposé invité Journées Nationales du GDR GPL 2024
Toxic effects of heavy metals : Lead and Arsenicsanjana502982
Heavy metals are naturally occuring metallic chemical elements that have relatively high density, and are toxic at even low concentrations. All toxic metals are termed as heavy metals irrespective of their atomic mass and density, eg. arsenic, lead, mercury, cadmium, thallium, chromium, etc.
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...Sérgio Sacani
We characterize the earliest galaxy population in the JADES Origins Field (JOF), the deepest
imaging field observed with JWST. We make use of the ancillary Hubble optical images (5 filters
spanning 0.4−0.9µm) and novel JWST images with 14 filters spanning 0.8−5µm, including 7 mediumband filters, and reaching total exposure times of up to 46 hours per filter. We combine all our data
at > 2.3µm to construct an ultradeep image, reaching as deep as ≈ 31.4 AB mag in the stack and
30.3-31.0 AB mag (5σ, r = 0.1” circular aperture) in individual filters. We measure photometric
redshifts and use robust selection criteria to identify a sample of eight galaxy candidates at redshifts
z = 11.5 − 15. These objects show compact half-light radii of R1/2 ∼ 50 − 200pc, stellar masses of
M⋆ ∼ 107−108M⊙, and star-formation rates of SFR ∼ 0.1−1 M⊙ yr−1
. Our search finds no candidates
at 15 < z < 20, placing upper limits at these redshifts. We develop a forward modeling approach to
infer the properties of the evolving luminosity function without binning in redshift or luminosity that
marginalizes over the photometric redshift uncertainty of our candidate galaxies and incorporates the
impact of non-detections. We find a z = 12 luminosity function in good agreement with prior results,
and that the luminosity function normalization and UV luminosity density decline by a factor of ∼ 2.5
from z = 12 to z = 14. We discuss the possible implications of our results in the context of theoretical
models for evolution of the dark matter halo mass function.
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...Ana Luísa Pinho
Functional Magnetic Resonance Imaging (fMRI) provides means to characterize brain activations in response to behavior. However, cognitive neuroscience has been limited to group-level effects referring to the performance of specific tasks. To obtain the functional profile of elementary cognitive mechanisms, the combination of brain responses to many tasks is required. Yet, to date, both structural atlases and parcellation-based activations do not fully account for cognitive function and still present several limitations. Further, they do not adapt overall to individual characteristics. In this talk, I will give an account of deep-behavioral phenotyping strategies, namely data-driven methods in large task-fMRI datasets, to optimize functional brain-data collection and improve inference of effects-of-interest related to mental processes. Key to this approach is the employment of fast multi-functional paradigms rich on features that can be well parametrized and, consequently, facilitate the creation of psycho-physiological constructs to be modelled with imaging data. Particular emphasis will be given to music stimuli when studying high-order cognitive mechanisms, due to their ecological nature and quality to enable complex behavior compounded by discrete entities. I will also discuss how deep-behavioral phenotyping and individualized models applied to neuroimaging data can better account for the subject-specific organization of domain-general cognitive systems in the human brain. Finally, the accumulation of functional brain signatures brings the possibility to clarify relationships among tasks and create a univocal link between brain systems and mental functions through: (1) the development of ontologies proposing an organization of cognitive processes; and (2) brain-network taxonomies describing functional specialization. To this end, tools to improve commensurability in cognitive science are necessary, such as public repositories, ontology-based platforms and automated meta-analysis tools. I will thus discuss some brain-atlasing resources currently under development, and their applicability in cognitive as well as clinical neuroscience.
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...Sérgio Sacani
Since volcanic activity was first discovered on Io from Voyager images in 1979, changes
on Io’s surface have been monitored from both spacecraft and ground-based telescopes.
Here, we present the highest spatial resolution images of Io ever obtained from a groundbased telescope. These images, acquired by the SHARK-VIS instrument on the Large
Binocular Telescope, show evidence of a major resurfacing event on Io’s trailing hemisphere. When compared to the most recent spacecraft images, the SHARK-VIS images
show that a plume deposit from a powerful eruption at Pillan Patera has covered part
of the long-lived Pele plume deposit. Although this type of resurfacing event may be common on Io, few have been detected due to the rarity of spacecraft visits and the previously low spatial resolution available from Earth-based telescopes. The SHARK-VIS instrument ushers in a new era of high resolution imaging of Io’s surface using adaptive
optics at visible wavelengths.
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...Scintica Instrumentation
Intravital microscopy (IVM) is a powerful tool utilized to study cellular behavior over time and space in vivo. Much of our understanding of cell biology has been accomplished using various in vitro and ex vivo methods; however, these studies do not necessarily reflect the natural dynamics of biological processes. Unlike traditional cell culture or fixed tissue imaging, IVM allows for the ultra-fast high-resolution imaging of cellular processes over time and space and were studied in its natural environment. Real-time visualization of biological processes in the context of an intact organism helps maintain physiological relevance and provide insights into the progression of disease, response to treatments or developmental processes.
In this webinar we give an overview of advanced applications of the IVM system in preclinical research. IVIM technology is a provider of all-in-one intravital microscopy systems and solutions optimized for in vivo imaging of live animal models at sub-micron resolution. The system’s unique features and user-friendly software enables researchers to probe fast dynamic biological processes such as immune cell tracking, cell-cell interaction as well as vascularization and tumor metastasis with exceptional detail. This webinar will also give an overview of IVM being utilized in drug development, offering a view into the intricate interaction between drugs/nanoparticles and tissues in vivo and allows for the evaluation of therapeutic intervention in a variety of tissues and organs. This interdisciplinary collaboration continues to drive the advancements of novel therapeutic strategies.
Slide 1: Title Slide
Extrachromosomal Inheritance
Slide 2: Introduction to Extrachromosomal Inheritance
Definition: Extrachromosomal inheritance refers to the transmission of genetic material that is not found within the nucleus.
Key Components: Involves genes located in mitochondria, chloroplasts, and plasmids.
Slide 3: Mitochondrial Inheritance
Mitochondria: Organelles responsible for energy production.
Mitochondrial DNA (mtDNA): Circular DNA molecule found in mitochondria.
Inheritance Pattern: Maternally inherited, meaning it is passed from mothers to all their offspring.
Diseases: Examples include Leber’s hereditary optic neuropathy (LHON) and mitochondrial myopathy.
Slide 4: Chloroplast Inheritance
Chloroplasts: Organelles responsible for photosynthesis in plants.
Chloroplast DNA (cpDNA): Circular DNA molecule found in chloroplasts.
Inheritance Pattern: Often maternally inherited in most plants, but can vary in some species.
Examples: Variegation in plants, where leaf color patterns are determined by chloroplast DNA.
Slide 5: Plasmid Inheritance
Plasmids: Small, circular DNA molecules found in bacteria and some eukaryotes.
Features: Can carry antibiotic resistance genes and can be transferred between cells through processes like conjugation.
Significance: Important in biotechnology for gene cloning and genetic engineering.
Slide 6: Mechanisms of Extrachromosomal Inheritance
Non-Mendelian Patterns: Do not follow Mendel’s laws of inheritance.
Cytoplasmic Segregation: During cell division, organelles like mitochondria and chloroplasts are randomly distributed to daughter cells.
Heteroplasmy: Presence of more than one type of organellar genome within a cell, leading to variation in expression.
Slide 7: Examples of Extrachromosomal Inheritance
Four O’clock Plant (Mirabilis jalapa): Shows variegated leaves due to different cpDNA in leaf cells.
Petite Mutants in Yeast: Result from mutations in mitochondrial DNA affecting respiration.
Slide 8: Importance of Extrachromosomal Inheritance
Evolution: Provides insight into the evolution of eukaryotic cells.
Medicine: Understanding mitochondrial inheritance helps in diagnosing and treating mitochondrial diseases.
Agriculture: Chloroplast inheritance can be used in plant breeding and genetic modification.
Slide 9: Recent Research and Advances
Gene Editing: Techniques like CRISPR-Cas9 are being used to edit mitochondrial and chloroplast DNA.
Therapies: Development of mitochondrial replacement therapy (MRT) for preventing mitochondrial diseases.
Slide 10: Conclusion
Summary: Extrachromosomal inheritance involves the transmission of genetic material outside the nucleus and plays a crucial role in genetics, medicine, and biotechnology.
Future Directions: Continued research and technological advancements hold promise for new treatments and applications.
Slide 11: Questions and Discussion
Invite Audience: Open the floor for any questions or further discussion on the topic.
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
Biosafety regulatory framework in Kenya
1. Program for Biosafety Systems – http://pbs.ifpri.info/
Biosafety Regulatory Framework in Kenya
Doris Wangari
Program for Biosafety Systems (PBS), Kenya
Animal Genetic Research for Africa
(Biosciences for Farming in Africa), Nairobi,
10-11 September 2015
2. Program for Biosafety Systems – http://pbs.ifpri.info/
Biosafety Act, 2009
Sets up the National Biosafety Authority as the
National focal point of all Biosafety matters in Kenya.
Makes provision for the establishment of a legal
framework for the safe handling, use and transfer of
Genetically modified organisms
NBA to exercise general supervision and control over
dealings in GMO with a view to ensuring safety to
human and animal health and protection of the
environment
3. Program for Biosafety Systems – http://pbs.ifpri.info/
Objects of the Act
• To facilitate responsible research into and
minimize the risks that may be posed by GMOs
• To ensure an adequate level of protection for safe
transfer, handling and use of GMOs that may have an
adverse effect on the health of the people and the
environment
• To establish a transparent, science‐based and
predictable process for reviewing and making
decisions on transfer, handling and use of GMOs
4. Program for Biosafety Systems – http://pbs.ifpri.info/
Mandate of the NBA
• To consider and determine applications for approval
for the development, transfer, handling and use
• To co-ordinate, monitor and assess activities relating
to the development, safe transfer, handling and use of
GMOs
• To co-ordinate research and monitor activities on all
GMO work in the country
• Strengthen national technical capacities and
capabilities for biosafety
• Develop regulations to operationalize the Biosafety
Act.
5. Program for Biosafety Systems – http://pbs.ifpri.info/
Cont…
• Establish and maintain a biosafety clearing house
(BCH) mechanism- web based information sharing
of national database linked to the international
BCH;
• Promote public awareness on biosafety and
biotechnology
• Enforce the provisions of the Biosafety Act
• Provide advisory services on matters of biosafety.
6. Program for Biosafety Systems – http://pbs.ifpri.info/
Regulatory Agencies
In enforcing the Biosafety law, the NBA collaborates with 8 regulatory
agencies as specified in the Biosafety Act.
These agencies include:
• Department of Public Health.
• Department of Veterinary Services (DVS).
• Kenya Bureau of Standards (KEBS).
• Pest Control Products Board (PCPB).
• Kenya Plant Health Inspectorate Service (KEPHIS).
• National Environmental Management Authority (NEMA).
• Kenya Wildlife Service (KWS).
• Kenya Industrial Property Institute (KIPI).
7. Program for Biosafety Systems – http://pbs.ifpri.info/
Role of Regulatory Agencies
• Monitor approved GMO activity to ensure
compliance with the conditions of approval
• Inform the Authority of any significant new
scientific information indicating that an approved
activity pose biosafety risk not previously known
• Inform the authority of unintentional or
unapproved introduction of a GMO into the
environment and propose mitigation measures
8. 8
Prepare and submit application to NBA
Communicate to
Applicant
Approved?
Start
Is dossier
complete?
Communicate
to Applicant
Yes
complete?
Yes
complete?
Not complete
Not complete
Communicate to Relevant Regulatory Agency(s)
and selected experts for review
Approval with/ without relevant conditions
The end
Submit review report to NBA
Communicate to
Applicant and Relevant
Regulatory agency(s)
Monitoring for adherence to approval conditions and
provisions of the Biosafety Law
9. Program for Biosafety Systems – http://pbs.ifpri.info/
BIOSAFETY REGULATIONS
The Law provided for gazettement of regulations that would
be important for the implementation of the Biosafety Act
2009;
To date 4 regulations have been gazetted: Regulations for;
• Contained Use (August 2011)
• Environmental Release (August 2011)
• Import, Export and Transit (August 2011)
• Regulations for Labeling (2012) e.g Foods and Feeds
10. Program for Biosafety Systems – http://pbs.ifpri.info/
1. Contained Use regulations
• These regulations cover activities involving GMOs
under containment and confinement
• They are typically applied during research on GMOs
(LAB, Green house, Screen, house CFT)
Objective (Art. 3)
• The objective of this Regulation is to ensure that
potential adverse effects of genetically modified
organism are addressed to protect human health and
the environment when conducting contained use.
11. Program for Biosafety Systems – http://pbs.ifpri.info/
2. Environmental Release Regulations
• This regulation covers activities involving release of
GMOs into the environment; placing on the market; etc
• Typically apply during commercialization
Requirements:
• A person shall not conduct any activity involving GMOs
without written approval from the Authority (Biosafety
Act, 2009, Art. 18)
• A person shall not make an environmental release or
place on market a GMO without the written approval of
the Authority.(Art. 5(1); 6 (1)
12. Program for Biosafety Systems – http://pbs.ifpri.info/
3. Import, Export & Transit Regulations
• These regulations cover activities involving importation
into, exportation out of and movement of GMOs through
Kenya
• Could touch on aspects of release or placing on market in
which case Regulations on Release apply
Objective (Art. 3)
• The objective of these Regulations is to ensure safe
movement of genetically modified organisms into and out
of Kenya while protecting human health and the
environment
13. Program for Biosafety Systems – http://pbs.ifpri.info/
4. Labeling Regulations
• To ensure that consumers are aware that food/feed or
product is GMO for informed choice
• To facilitate traceability of GMO products towards
enforcement of appropriate management measures
• Application: Foods consisting of GMO or derived from
GMO
• Exemptions: Where GMO is below 1% threshold level,
Highly refined foods devoid of GMO, Food additives,
Food intended for consumption
16. Program for Biosafety Systems – http://pbs.ifpri.info/
PROJECT INSTITUTION DATE APPROVED
Cassava Mosaic virus
Resistant cassava( VIRCA
Project)
KALRO 18th Jan., 2011
Cassava Brown Streak
Disease Resistance
(VIRCA Project)
KALRO 26th Sept., 2013
Gypsophila Project for Pink
Colour flower stability
KALRO 3rd Dec., 2013
Transgenic cassava expressing
African cassava
Mosaic virus (ACMV) and cassava
brown streak virus (CBSV)
resistance
Masinde Muliro
University of Science
and Technology
(MMUST)
6th March, 2014
17. Program for Biosafety Systems – http://pbs.ifpri.info/
PROJECT INSTITUTION DATE
APPROVED
Confined Field Trial (CFT) to evaluate
sweet potato containing genetic
elements conferring siRNA resistance
to sweet potato virus disease.
KALRO 21st July,
2014
Trials of transgenic sorghum
containing pro-‐vitamin A and
enhanced iron and zinc bio-
availability
KALRO 4th March,
2015